GlobeNewswire by notified

New Data Reveals The Financial Impact Of The Pandemic On Holidays

Share

Latest data from trivago shows a real appetite from travellers to make 2022 ‘the best summer ever’

New data from trivago (using One Poll) reveals that travel restrictions during the pandemic saved would-be travellers an average of £1887.70, with almost one-in-ten (8%) saying they saved over £5000. When asked what they have done with the money, 45% said they put it in a savings account, 22% treated themselves, 20% put it towards a large purchase and 19% put it towards rent or a deposit for a house.

As travel restrictions finally lift, the appetite to travel is recovering strongly. Of those who generally have at least one holiday a year, a third (33%) have already made firm plans to travel in 2022 and a further 21% have made tentative plans. In total, over a third (34%) say they have been browsing/investigating future holidays more than before the pandemic.

The pandemic has also increased Brits willingness to spend more on their travel habits - almost four-in-ten (37%) travellers plan on spending more on their holidays. This rises to two-thirds (66%) of 18- to 24-year-olds. Where travellers reside has a marked impact in spending. Whilst over half (55%) of Londoners are planning on spending more on their holidays this year, only 20% of travellers from East Anglia are willing to dig deeper into their wallet. In total, it is the over 65s who remain the most cautious, with 18% saying they will likely spend less than if the pandemic hadn’t happened.

However, despite Brits saving money by being unable to travel during the pandemic, wannabe travellers are still more concerned about their finances than their health. In fact, the research revealed that 48% of UK travellers would make concrete plans if they could guarantee their money back should they get their holiday cancelled, compared with 33% who said they would be more likely to book if there was a guaranteed low risk of catching Covid-19.

Percentage of travellers willing to spend more on their holiday than they would have done pre-pandemic, by region:

Column %
n
East AngliaEast MidlandsLondonNorth EastNorth WestNorthern IrelandScotlandSouth EastSouth WestWalesWest MidlandsYorkshire and the Humber
Much more 3% 2% 24% 11% 7% 0% 15% 7% 9% 15% 15% 10%
4 3 59 7 14 0 23 18 15 12 23 13
A little more 17% 22% 31% 31% 26% 41% 20% 32% 25% 26% 28% 17%

“Expectations are high that this could be the best summer ever. Of those who have firm plans to travel, over half (51%) believe that 2022 is going to be their best summer yet for travel,” comments Axel Hefer, CEO of trivago. “Travellers are tired of waiting for a dream getaway. Three-in-ten (30%) told us they are planning on organising a ‘bucket list' holiday sooner than originally thought due to the pandemic.”

ENDS

Notes to Editors:

The survey was deployed online and ran from February 25-March 3, 2022 polling a sample of 2,000 adults age 18+ in both countries for a total of 4,000 respondents. For both countries, quotas were used to ensure an accurate representation of each countries’ population by gender, age, geographic region, education, and income.

About Trivago:

trivago is a leading global hotel search platform focused on reshaping the way travelers search for and compare hotels and alternative accommodations. Incorporated in 2005 in Düsseldorf, Germany, the platform allows travelers to make informed decisions by personalizing their hotel search and providing them access to a deep supply of hotel information and prices. trivago enables its advertisers to grow their businesses by providing access to a broad audience of travelers via its websites and apps.

Press Contact

Contacts:
Press Contact: Trivago Unity Team trivago@hellounity.com

Forward-looking statements

This press release contains certain forward-looking statements. Words, and variations of words such as “believe,” “expect,” “plan,” “continue,” “will,” “should,” and similar expressions are intended to identify our forward-looking statements. These forward-looking statements involve risks and uncertainties, many of which are beyond our control, and important factors that could cause actual events and results to differ materially from those in the forward-looking statements. For additional information factors that could affect our forward-looking statements, see our risk factors, as they may be amended from time to time, set forth in our public filings with the Securities and Exchange Commission. We disclaim and do not undertake any obligation to update or revise any forward-looking statement in this press release, except as required by applicable law or regulation.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Adevinta (ASA) publishes its 2023 Annual Report26.4.2024 08:30:00 CEST | Press release

Oslo, 26 April 2024 – Adevinta ASA today released its 2023 Annual Report, available here. A printed copy may be obtained free of charge upon written request to: ir@adevinta.com. Reflecting on 2023, Antoine Jouteau, CEO, said: “Over the past year, we have made significant progress on redesigning our operating model, verticalising our organisation in line with our Growing At Scale strategy and successfully completing our portfolio optimisation. We have achieved strong financial and operational performance in 2023 and continued to deliver against our targets, despite the tough macroeconomic environment. Following the divestment of our Hungarian classifieds business, our portfolio is now centred around our core European markets of France, Germany, Spain, Italy and Benelux, complemented by Canada and our joint ventures. We are delivering significant growth in our Mobility, Re-Commerce and Real Estate & Emerging verticals, substantiating our focus in these areas. By putting technology and pr

PCI Biotech Holding ASA - Annual Report 202326.4.2024 08:08:19 CEST | Press release

Oslo, Norway, April 26, 2024. The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as well as the report according to the European Single Electronic Format (ESEF). The Annual Report 2023 is also available on the company’s website www.pcibiotech.com. For further information, please contact: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Ronny Skuggedal, CEO, rs@pcibiotech.no, Mobile: +47 940 05 757 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachments 2023 Annual Report PCI Biotech Holding ASApcibiotechholdingasa-2023-12-31-en

Delårsrapport för januari – mars 202426.4.2024 08:00:00 CEST | Pressemelding

STOCKHOLM – den 26 april 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) publicerar idag sin delårsrapport för januari – mars 2024. Den fulla rapporten är tillgänglig på bolagets hemsida. ”Det har varit en stark inledning på 2024 där utvecklingen inom respektive portföljbolag löper enligt plan. Trots att vi haft ett motigt marknadsklimat har våra portföljbolag outtröttligt fortsatt driva utvecklingen av framtidens behandlingar vidare för att de så snabbt som möjligt ska komma patienterna till gagn. Vi ser fram emot tilltagande medvind och fler framsteg under året”, säger Viktor Drvota, VD, Karolinska Development. Väsentliga händelser under första kvartalet Portföljbolaget OssDsign rapporterade positiva data från den kliniska studien TOP FUSION. Top-line-resultaten, som granskats av oberoende radiologer, visar en fusionsgrad på 93 procent 12 månader efter operation med det nya nanosyntetiska bengraftet OssDsign Catalyst (januari 2024).Portföljbolaget AnaCardio erhöll SEK 50 mil

Interim Report - January-March 202426.4.2024 08:00:00 CEST | Press release

STOCKHOLM – 26 April 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report - January-March 2024. The full report is available on the Company's website. “2024 has begun strongly with development within the respective portfolio companies proceeding according to plan. The adverse market climate we have previously experienced notwithstanding, our portfolio companies have continued tirelessly to advance the development of tomorrow’s treatments in order that patients can reap the benefits as quickly as possible. We look forward to an increasing tailwind and further progress during the year”, says Viktor Drvota, CEO, Karolinska Development. Significant events during the first quarter The portfolio company OssDsign reported positive data from the clinical study TOP FUSION. Top-line results show a 93% spinal fusion rate at 12 months as assessed with CT by independent radiological review after surgery with the novel nanosynthetic bone graft OssDsign Catalyst

Solvay publishes notice of 2024 Annual General Meeting26.4.2024 08:00:00 CEST | Press release

Brussels, April 26, 2024, 8:00am CEST - regulated information Solvay today published materials for its next Ordinary General Shareholders’ Meeting, which will be held on Tuesday May 28, 2024 at the Event Lounge Conference Center, Boulevard Général Wahis 16/F, 1030 Brussels, at 10.30 am CEST. All documents relating to this meeting are now available on www.solvay.com. Shareholders will be asked to vote on a number of resolutions, among others: the approval of the financial statements for the financial year 2023; the approval of a total gross dividend of €2.43 per share; the approval of the revised directors’ remuneration; the renewal of the mandate, for a four-year period, of Ms Aude Thibaut de Maisières, as Director of the company; the appointment of EY regarding the assurance of sustainability information imposed by the EU Directive on sustainability reporting (Corporate Sustainability Reporting Directive); the approval of the change of control provision relating to the issuance of eur

HiddenA line styled icon from Orion Icon Library.Eye